Status:
COMPLETED
Efficacy and Safety of Azithromycin in Patients With Bronchiolitis Obliterans
Lead Sponsor:
Claudio Castanos
Conditions:
Bronchiolitis Obliterans
Eligibility:
All Genders
5-18 years
Phase:
PHASE4
Brief Summary
Placebo-controlled, double-blind, randomized study. Post-infectious bronchiolitis obliterans (PIBO) patients aged 5 years and older of both sexes were enrolled.
Detailed Description
Bronchiolitis obliterans (BO) was defined as the presence of signs and symptoms of chronic obstructive lung disease: A) previously documented acute lower respiratory infection (ALRI) with persistence ...
Eligibility Criteria
Inclusion
- Patients with diagnosis of Bronchiolitis obliternas
- older than 5 years
- Ability to perform pulmonary function test
Exclusion
- Not being able to perform lung function study adequately
- Other causes of chronic lung disease (bronchopulmonary dysplasia, cystic fibrosis, primary or secondary immune deficiency)
- Previous history of portal hypertension, liver cirrhosis, splenomegaly or chang in normal values of laboratory at the start of the study.
- History of hypersensitivity to macrolides
Key Trial Info
Start Date :
August 24 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 21 2011
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05299567
Start Date
August 24 2010
End Date
July 21 2011
Last Update
March 29 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.